Highlights and cutting-edge advances in hepatobiliary and pancreatic cancer research at the European Society of Medical Oncology(ESMO)Asia Congress 2024
10.7659/j.issn.1005-6947.250032
- VernacularTitle:2024年欧洲肿瘤内科学会亚洲年会(ESMO Asia Congress)肝胆胰肿瘤研究热点与前沿动态
- Author:
Zhihao HUANG
1
;
Jinming WANG
;
Leipo LIN
;
Guogao QIU
;
Zhidong LIU
;
Zhicheng LI
;
Jianhong ZHONG
Author Information
1. 广西医科大学附属肿瘤医院肝胆胰脾外科,广西南宁 530021
- Publication Type:Journal Article
- Keywords:
Liver Neoplasms;
Biliary Tract Neoplasms;
Pancreatic Neoplasms;
ESMO Asia
- From:
Chinese Journal of General Surgery
2025;34(1):124-136
- CountryChina
- Language:Chinese
-
Abstract:
The European Society for Medical Oncology Asia Congress 2024 was held in Singapore from December 6 to 8,2024.The conference unveiled several groundbreaking studies in the field of hepatobiliary and pancreatic tumors,covering clinical applications related to neoadjuvant and adjuvant therapies,translational treatments,later-line therapies,and tumor biomarkers.These studies provide new insights into the clinical diagnosis and treatment of hepatobiliary and pancreatic malignancies and drive the development of related fields.This article focuses on the key topics in hepatobiliary and pancreatic malignancies presented at the conference,aiming to interpret the latest advances in the field and explore the hot issues and future directions for development in this area.
